Skystar Bio-Pharmaceutical Co

Company Snapshot
No. 48 Keji Road
Xian, Shaanxi Province
China
Sector: Healthcare
Industry: Drug Manufacturers - Major
Full Time Employees: 318
http://www.skystarbio-pharmaceutical.com
Please select from the dropdown
  1. Executive Compensation
  2. > Skystar Bio-Pharmaceutical Co
Company Financials

2011
2012
2013
Gross Profit
$26,225,531
$18,491,787
$21,490,754
Operating Income
$15,249,924
$8,550,981
$13,012,864
Net Income
$13,657,640
$6,212,428
$10,530,252
2011
Gross Profit
$26,225,531
Operating Income
$15,249,924
Net Income
$13,657,640
2012
Gross Profit
$18,491,787
Operating Income
$8,550,981
Net Income
$6,212,428
2013
Gross Profit
$21,490,754
Operating Income
$13,012,864
Net Income
$10,530,252
The above data on Skystar Bio-Pharmaceutical Co came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Weibing Lu
Chairman of the Board and Chief Executive Officer
$243,102
$0
$0
$243,102
Weibing Lu
$243,102
Chairman of the Board and Chief Executive Officer
R. Cramer
Director
$30,000
$118,930
$0
$148,930
R. Cramer
$148,930
Director
Mark Chen
Independent Director
$14,000
$9,973
$0
$23,973
Mark Chen
$23,973
Independent Director
Chengtun Qu
Independent Director
$3,231
$0
$0
$3,231
Chengtun Qu
$3,231
Independent Director
Weirong Shen
Independent Director
$3,231
$0
$0
$3,231
Weirong Shen
$3,231
Independent Director
Skystar Bio-Pharmaceutical Co listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2013. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us